Luke Timmerman's Team Kilimanjaro

Congrats Team Kilimanjaro for raising $1 Million

After a successful summit of Mt. Everest, Luke Timmerman has set his sights on Mt. Kilimanjaro, the highest peak in Africa. Formed by biotech executives and investors from around the country, Team Kilimanjaro will travel to Tanzania, Africa in July 2019.

Team Kilimanjaro climbers will each raise $50,000 or more to support cancer research at Fred Hutch. The team has already raised $1 million and aims to raise at least another $300,000 before departing for Mt. Kilimanjaro in July.

To mail in a donation, please send to the address below, indicating the climber you wish to donate to in the subject line. For stock donations or bank transfer instructions, please email

Fred Hutch
ATTN: Climb to Fight Cancer
1100 Fairview Ave N, Mail Stop J5-200
Seattle, WA 98109


  • Lesley Stolz, EVP & Chief Business Officer, Annexon Biosciences
  • Simba Gill, CEO, Evelo Biosciences; Venture Partner, Flagship Pioneering
  • Heidi Hagen, Chief Strategy Officer and Co-Founder, Vineti
  • Kirsten Axelsen, Visiting Fellow American Enterprise Institute and Healthcare Consultant
  • Deaidra Smith, Director of Portfolio Communications, Alexion Pharmaceuticals
  • Nancy Hong, Managing Director, RiverVest Venture Partners
  • Ken Brunt, Vice President of Customer Operations, Veracyte
  • Peter Faroni, Co-founder and Partner, Madryn Asset Management
  • Oren Beske, SVP, Corporate Strategy and Development, ATUM

Fundraising goal:

$1,300,000 / $50,000 per climber


19,340 feet

Guide service:

Alpine Ascents International (AAI)


Nektar Therapeutics
Alexandria Real Estate Equities
Exact Sciences
Alexion Pharmaceuticals
Foundation Medicine
Johnson & Johnson Innovation, JLABS
Madryn Asset Management
RiverVest Venture Partners
Takeda Pharmaceuticals
5AM Ventures
Antibody Solutions
Blueprint Medicines
JP Morgan
Mirati Therapeutics, Inc
Moore & Van Allen, PLLC
Toft Group


Seattle Cancer Summit, May 10